In the News
In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.
04/21/2022
Using NLP Technology To Uncover Real-World Patient Insights
It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years.
01/13/2022
Dr. Ali on the Need to Understand Real-World Disparities in BRCA Testing in TNBC
During the 2021 San Antonio Breast Cancer Symposium, findings from a real-world analysis evaluating racial disparities in BRCA testing for patients with TNBC were presented in a virtual poster. The results showed that the rate of BRCA testing was high overall in evaluated patients with TNBC, although a larger proportion of White patients received testing compared with Black or African American patients.
01/10/2022
Achieving Comprehensive Patient Care Using Natural Language Processing
Telehealth has seen unprecedented growth within the past few years. As a result of this adoption, at the onset of the COVID-19 pandemic, health care organizations were quickly able to adapt their processes from being rooted in in-person care to relying on virtual care.
Press Releases
04/07/2022
Five Leading Real-World Data and Analytics Organizations Join the RWE Alliance, Doubling Membership
Washington, D.C.(April 5, 2022) – The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE).
03/31/2022
Syapse Announces Changes to Board of Directors, Adding Michael Mentesana and Elevating Frank Williams to Chairman Role
SAN FRANCISCO, March 31, 2022 — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that long-time board member and health industry veteran Frank Williams has been named as Chairman of the company’s board of directors. Additionall…
03/22/2022
Main Line Health Collaborates with Syapse, Bringing Clinical Trial Opportunities to Patients with Cancer in Philadelphia Region
San Francisco, CA – March 17, 2022 – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced a collaboration with Main Line Health, home to four of the Philadelphia region’s most respected acute care hospitals. Main Line Health will utilize the Syapse…
Events
Webinar
The path to revolutionized cancer care: Accessing data to rapidly generate patient insights to impact care
March 10, 2022
Cancer Care is being revolutionized with real-world data, which tells a comprehensive story for cancer patients. Oncology and technology leaders are always searching for creative approaches to reduce the complexity of exchanging data across multiple platforms. However, when making a sizable investment in getting access to the data you need to inform clinical decision-making, it’s essential to have an engine that can provide out–of–the–box capabilities and the flexibility to manage customizations. In this fireside chat, health-tech experts from Syapse and Infor will discuss the benefits of working in tandem to streamline oncology data acquisition to improve outcomes for cancer patients.